Historical cl News Stories
Colgate's $919M Hit, Toothpaste Share & Pet Push!!
Colgate‑Palmolive reported a $919M pre-tax impairment in its Skin Health segment while oral-care volumes dipped despite price increases. Regulatory settlements over children’s toothpaste packaging and continued strength in toothpaste share and Hill’s pet nutrition expansion shape near-term pressures and long-term diversification.
Colgate Gains: WHO Tie‑Up and Morgan Stanley Lift!
Colgate‑Palmolive received a meaningful boost after announcing a multi‑year collaboration with the WHO Foundation and securing renewed analyst support from Morgan Stanley. These concrete developments strengthened the stock’s defensive narrative, produced a near‑term share uptick, and provided measurable analyst upside—while leaving the immediate earnings profile largely unchanged.
Colgate’s WHO Deal Fuels CL Stock Surge to $93 Now
Colgate‑Palmolive’s new WHO Foundation partnership and subsequent analyst upgrades lifted CL shares roughly 5–6% as firms like JPMorgan and BNP raised price targets to about $93.
CL Stock Strengthens After WHO Oral-Health Tie-up.
Colgate‑Palmolive (CL) showed resilient share performance and rising technical momentum this week after announcing a WHO Foundation partnership. Improved relative strength, modest analyst upside and solid dividend metrics frame a cautious but constructive view for investors.